Q32 BIO INC (QTTB) Stock Income Statement
NASDAQ:QTTB - Nasdaq - US7469641051 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 1.16M | 3.21M | 33.97M | 2.70M | |||
| Operating Expenses | 66.10M | 93.26M | 136.49M | 129.92M | 132.97M | |||
| Research and Development | 48.14M | 62.00M | 98.35M | 93.09M | 100.39M | |||
| Selling, General, and Administrative Expenses | 17.96M | 31.26M | 38.14M | 36.84M | 32.57M | |||
| Operating Income | -66.10M | -92.10M | -133.28M | -95.95M | -130.26M | |||
| Interest Income/Expense | 5.00M | 5.58M | 3.23M | 190.00K | 1.57M | |||
| Other Income/Expense | 15.71M | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | -700.00K | -560.00K | 131.25M | N/A | N/A | |||
| Income Before Taxes | -46.09M | -87.08M | 1.20M | -95.76M | -128.69M | |||
| Income Tax | 21.00K | 0.00 | 720.00K | N/A | N/A | |||
| Net Income | -47.73M | -112.96M | -5.01M | -95.76M | -128.69M | |||
| EBITDA | -65.62M | -91.52M | -131.99M | -87.60M | -122.29M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.12 | -35.16 | -0.09 | -1.73 | -2.80 | |||
| Non GAAP EPS | -18.99 | -26.78 | -1.90 | -1.69 | -2.80 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -9771.71% | -156.07% | -281.90% | -4766.30% | |||
| Operating Profit Margin | N/A | -7967.30% | -4152.02% | -282.46% | -4824.44% | |||
All data in USD